Hopefully CYDY will submit for and get approved to start a cancer basket trial that was mentioned in a PR a few weeks ago. That would save time and money vs running trials very every single type of cancer that may respond to leronlimab. Not sure if CYDY is actively building a phase 2 protocol for a basket trial but I’d assume it’s high on the list considering the results from the mTNBC patient.